GKIM
HPTX

GW&K Investment Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

GW&K Investment Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-68,650
Closed -$1.65M – 234
2014
Q4 		$1.65M Buy
68,650
+8,830
+15% +$199K 0.04% 186
2014
Q3 		$1.51M Buy
59,820
+13,615
+29% +$338K 0.04% 190
2014
Q2 		$1.21M Buy
46,205
+24,620
+114% +$633K 0.03% 192
2014
Q1 		$557K Buy
+21,585
New +$585K 0.01% 196

Other funds holding HPTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GW&K Investment Management's HPTX Position: Q1 2015 in Review

GW&K Investment Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q1 2015, closing a stake of 68,650 shares — an estimated $1.65M sold.

GW&K Investment Management first reported a position in HPTX in Q1 2014 and held it in 4 quarters. The position peaked at $1.65M in Q4 2014. 134 funds tracked by Wall St. Rank hold HPTX as of Q1 2015.

  • GW&K Investment Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • GW&K Investment Management sold 68,650 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q1 2015, an estimated $1.65M.
  • GW&K Investment Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 4 quarters.
  • GW&K Investment Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.65M in Q4 2014.
  • 134 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q1 2015.

Based on GW&K Investment Management's 13F filing for Q1 2015, filed 8 Apr 2015.